Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation.
Frequently asked questions
What sector does Pegavision (6491) operate in?
Pegavision belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Pegavision (6491) current stock price?
As of the latest data, Pegavision stock price is NT$367.50, with a previous close of NT$366.50. Pegavision gained NT$1.00 in the last trading session, representing a 0.27% increase.
What is Pegavision (6491) current market capitalization?
Pegavision market cap is approximately 28.24 billion.
What is Pegavision (6491) Earnings Per Share (EPS)?
The trailing EPS is NT$23.55, and the forward EPS is NT$29.12.
What is Pegavision (6491) Price-to-Earnings (P/E) ratio?
Pegavision current P/E ratio is 15.61, with a forward P/E of 12.62.
What is Pegavision (6491) EBITDA?
Pegavision EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 812.55 million.
Does Pegavision (6491) pay dividends?
Yes. Pegavision pays annual dividends with an annualized yield of 2.72% and an estimated annual payout of NT$10.01 per share.
When is the next ex-dividend date for Pegavision (6491)?
The next ex-dividend date is scheduled for August 07, 2027.
How did Pegavision (6491) perform in its most recent earnings report?
In the last report (June 30, 2026), Pegavision posted an EPS surprise of 20% and a revenue surprise of 7.55%.
What is Pegavision (6491) beta (volatility) score?
Pegavision has a beta of 0.772, indicating lower volatility than the overall market.
